Use of Propensity Scores To Design Observational Comparative Effectiveness Studies.
作者信息
Glynn Robert J
机构信息
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
出版信息
J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw345.
Abstract
摘要
相似文献
1
Use of Propensity Scores To Design Observational Comparative Effectiveness Studies.
J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw345.
2
Applications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?
J Comp Eff Res. 2014 Jan;3(1):63-78. doi: 10.2217/cer.13.89. Epub 2013 Nov 22.
3
Regulatory considerations in the design of comparative observational studies using propensity scores.
J Biopharm Stat. 2012;22(6):1272-9. doi: 10.1080/10543406.2012.715111.
4
Propensity score models in observational comparative effectiveness studies: cornerstone of design or statistical afterthought?
J Comp Eff Res. 2012 Mar;1(2):129-35. doi: 10.2217/cer.12.4.
5
Handling missing data in propensity score estimation in comparative effectiveness evaluations: a systematic review.
J Comp Eff Res. 2018 Mar;7(3):271-279. doi: 10.2217/cer-2017-0071. Epub 2017 Oct 5.
6
Propensity scores for comparative effectiveness research: Finding the right match.
Surgery. 2016 Dec;160(6):1425-1426. doi: 10.1016/j.surg.2016.05.045. Epub 2016 Jul 30.
7
[The propensity score method and it's application].
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Jul 6;53(7):752-756. doi: 10.3760/cma.j.issn.0253-9624.2019.07.017.
8
Comparing drug effectiveness in children: A systematic review.
Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1295-1301. doi: 10.1002/pds.4676. Epub 2018 Oct 31.
9
Performing both propensity score and instrumental variable analyses in observational studies often leads to discrepant results: a systematic review.
J Clin Epidemiol. 2015 Oct;68(10):1232-40. doi: 10.1016/j.jclinepi.2015.04.003. Epub 2015 Apr 8.
10
Propensity Score-Based Methods in Comparative Effectiveness Research on Coronary Artery Disease.
Am J Epidemiol. 2018 May 1;187(5):1064-1078. doi: 10.1093/aje/kwx214.
引用本文的文献
1
Association between intraoperative steroid and postoperative mortality in patients undergoing craniotomy for brain tumor.
Front Neurol. 2023 Jun 29;14:1153392. doi: 10.3389/fneur.2023.1153392. eCollection 2023.
2
Ten Rules for Conducting Retrospective Pharmacoepidemiological Analyses: Example COVID-19 Study.
Front Pharmacol. 2021 Jul 28;12:700776. doi: 10.3389/fphar.2021.700776. eCollection 2021.
本文引用的文献
1
Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies.
J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw323.
2
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.
Curr Epidemiol Rep. 2015 Dec;2(4):221-228. doi: 10.1007/s40471-015-0053-5. Epub 2015 Sep 30.
3
Metformin and the risk of cancer: time-related biases in observational studies.
Diabetes Care. 2012 Dec;35(12):2665-73. doi: 10.2337/dc12-0788.
4
Clinical referral patterns for carotid artery stenting versus carotid endarterectomy: results from the Carotid Artery Revascularization and Endarterectomy Registry.
Circ Cardiovasc Interv. 2011 Feb 1;4(1):88-94. doi: 10.1161/CIRCINTERVENTIONS.110.958843. Epub 2011 Jan 11.
5
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.
Am J Epidemiol. 2010 Oct 1;172(7):843-54. doi: 10.1093/aje/kwq198. Epub 2010 Aug 17.
6
On the limitations of comparative effectiveness research.
Stat Med. 2010 Aug 30;29(19):1991-5; discussion 1996-7. doi: 10.1002/sim.3960.
7
Different methods of balancing covariates leading to different effect estimates in the presence of effect modification.
Am J Epidemiol. 2009 Apr 1;169(7):909-17. doi: 10.1093/aje/kwn391. Epub 2009 Jan 19.
8
Immortal time bias in pharmaco-epidemiology.
Am J Epidemiol. 2008 Feb 15;167(4):492-9. doi: 10.1093/aje/kwm324. Epub 2007 Dec 3.
9
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results.
Med Care. 2007 Oct;45(10 Supl 2):S131-42. doi: 10.1097/MLR.0b013e318070c08e.
10
The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
Stat Med. 2007 Jan 15;26(1):20-36. doi: 10.1002/sim.2739.
Zotero 插件